BIO Quote, Trading Chart, Bio-Rad Laboratories Inc. Class A
$572.215 Last:
-3.21% Change Percent:
$588.11 Open:
$572.215 Previous Close:
$589.715 High:
$571.22 Low:
35,984 Volume:
03/03/2021 12:56:10 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-03 | 588.11 | 572.215 | 589.715 | 571.22 | 35,984 |
| 2021-03-02 | 598.88 | 591.22 | 600.21 | 586.68 | 145,062 |
| 2021-03-01 | 590.26 | 597.3 | 602.36 | 590.26 | 157,404 |
| 2021-02-26 | 588.6 | 584.5 | 592.92 | 578 | 242,311 |
| 2021-02-25 | 593.83 | 582.45 | 596.51 | 579.12 | 264,613 |
| 2021-02-24 | 592.08 | 594.74 | 605.1 | 584.01 | 197,752 |
| 2021-02-23 | 599.17 | 594.48 | 599.17 | 582.14 | 279,418 |
| 2021-02-22 | 632.81 | 603.54 | 632.81 | 602.5 | 260,776 |
| 2021-02-19 | 653.58 | 637.01 | 656.71 | 634.12 | 373,380 |
| 2021-02-18 | 653.77 | 651.5 | 667.71 | 649 | 195,435 |
| 2021-02-17 | 651.45 | 655.72 | 658.45 | 646.5 | 121,569 |
| 2021-02-16 | 661.31 | 649.62 | 665.95 | 647.46 | 343,673 |
| 2021-02-15 | 650 | 662.35 | 689 | 649.95 | 533,130 |
| 2021-02-12 | 650 | 662.35 | 689 | 649.95 | 532,605 |
| 2021-02-11 | 636.3 | 643.81 | 644.29 | 626.11 | 330,360 |
| 2021-02-10 | 642.5 | 631.92 | 647.15 | 626.905 | 352,218 |
| 2021-02-09 | 628.55 | 636.46 | 645 | 627.88 | 291,981 |
| 2021-02-08 | 620 | 628.68 | 636.27 | 619.9 | 230,099 |
| 2021-02-05 | 608.62 | 616.48 | 619.84 | 607.85 | 212,778 |
| 2021-02-04 | 589.24 | 605.01 | 607.615 | 587.125 | 223,008 |
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive Vice President and COO; and Ilan Daskal, Executive Vice President and CFO will part...
-
Image source: The Motley Fool. Bio-Rad Laboratories Inc (NYSE: BIO) Q4 2020 Earnings Call Feb 11, 2021 , 6:00 p.m. ET Operator Continue reading For further details see: Bio-Rad Laboratories Inc (BIO) Q4 2020 Earnings Call Transcript
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the fourth quarter ended December 31, 2020. Fourth-quarter 2020 net sales were $789.8 million, an increase of 26.5 percen...